According to the WHO Eastern Mediterranean Regional Office (WHO/EMRO) (2007), the EM Region will have the largest increase in cancer incidence among the WHO regions in the next 15 years; an increase of 100% to 180%. In addition, the mortality ratio is 70%, indicating the lower survival rate from diagnosed cancer.
Cancer is a real challenge in the region. In this regard, WHO/EMRO has issued in 2007 a Regional Strategy for Cancer Control that aims at providing a foundation for the development of a coordinated approach and to support member states in setting their national cancer control programs. The Regional Strategy also highlights the need to emphasize improved communication and regional collaboration such that the benefits of concerted action can be realized. EMRA aspires to intervene with regards to the WHO/EM Regional strategy for Cancer control.
EMRA defines its priority action as to help WHO/EMRO implementing its regional strategy to fight this blast; meaning contributing to the implementation in each country of the Region of the WHO basic components for cancer control: prevention, early detection, treatment, palliative care, registry and cancer research. This could be done only if each country draws up its national cancer control program. Strengthened by the unwavering support provided by WHO and through the partnership with the governments of the Region, this Alliance will not only contribute to the urgent need of minimizing cancer impacts in the Region but also to build a strong advocacy at the regional and international level.
Thanks to the impetus given by HRH Princess Lalla Salma as Honorary President of EMRA against cancer and as WHO goodwill Ambassador for the promotion of cancer prevention and care in EM region, EMRA will encourage cancer-related stakeholders to work together to harmonize their activities at the regional level.
EMRA against Cancer broad strategy is defined by the Board of Directors. It composed of 16 members at most elected for 3 years by the General Assembly.
The Board of Directors comprises an Office composed of:
Besides, a Scientific Council composed of great national and international oncology-related doctors is dedicated to direct the Board of Directors on medical actions that the Alliance will undertake, as well on the technical means helping the Alliance to fulfil its goals.
Regarding the running tasks, the Board of Directors appoints a Director General who is responsible for the administrative and technical management as well as the regional coordination of the Alliance activities.
Elected board Of Directors
|President||Dr. Moulay Tahar Alaoui||Lalla Salma Foundation for Cancer prevention and treatment||Morocco|
|First Vice-President||Dr. Ibrahim Fahad Al Sheneber||Saudi Cancer Foundation||Saudi Arabia|
|Second Vice-President||Dr. Mohamed Shaalan||Breast Cancer Foundation of Egypt||Egypt|
|Third Vice-President||Dr. Sherif Omar||Fakous Cancer Center||Egypt|
|Secretary General||Dr. Mohamed Adel Elsayes||Saudi Cancer Foundation||Saudi Arabia|
|Dr. Leila Laalou Alaoui||National Oncology Institute Friends||Morocco|
|Treasurer||Ms. Fatima Chraibi Smires||Association Avenir (Future Association)||Morocco|
|Vice Treasurer||Doctor Rajae Aghzadi||Women’s Heart Association (Association Coeur des Femmes)||Morocco|
|President of the Board of Directors||Dr. Moulay Tahar Alaoui|
|General Director||Dr. Rachid Bekkali|
|Head of the scientific Committee||Dr. Abdellatif Benider|